AGWCA
RCUS icon

Annis Gardner Whiting Capital Advisors’s Arcus Biosciences RCUS Stock Holding History

Annis Gardner Whiting Capital Advisors’s Portfolio RCUS Stock Details RCUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.04K Hold
48
– – ﹤0.01% 1143
2025
Q4 		$1.14K Hold
48
– – ﹤0.01% 1030
2025
Q3 		$653 Hold
48
– – ﹤0.01% 1048
2025
Q2 		$391 Buy
+48
New +$410 ﹤0.01% 1211

Other funds holding RCUS

GS
Gilead Sciences Foster City, California $2.12B AUM 143.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return

Annis Gardner Whiting Capital Advisors's RCUS Position: Q1 2026 in Review

Annis Gardner Whiting Capital Advisors held its Arcus Biosciences (RCUS) position steady in Q1 2026 at 48 shares worth $1.04K. The position accounts for ﹤0.01% of the portfolio, ranked #1143.

Annis Gardner Whiting Capital Advisors first reported a position in RCUS in Q2 2025 and has held it in 4 quarters since. The position peaked at $1.14K in Q4 2025. 210 funds tracked by Wall St. Rank hold RCUS as of Q1 2026.

  • Annis Gardner Whiting Capital Advisors held 48 shares of Arcus Biosciences worth $1.04K as of Q1 2026.
  • Annis Gardner Whiting Capital Advisors left its Arcus Biosciences share count unchanged in Q1 2026.
  • Arcus Biosciences made up ﹤0.01% of Annis Gardner Whiting Capital Advisors's portfolio in Q1 2026, its #1143 holding.
  • Annis Gardner Whiting Capital Advisors first reported a position in Arcus Biosciences in Q2 2025 and has held it in 4 quarters since.
  • Annis Gardner Whiting Capital Advisors's Arcus Biosciences position peaked at $1.14K in Q4 2025.
  • 210 funds tracked by Wall St. Rank held Arcus Biosciences as of Q1 2026.

Based on Annis Gardner Whiting Capital Advisors's 13F filing for Q1 2026, filed 6 May 2026.